Lobbying Update: $700,000 of HCA HEALTHCARE INC. lobbying was just disclosed

$700,000 of HCA HEALTHCARE INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"HR977/S470, Patient Access to Higher Quality Health Care Act of 2023; HR5378, Lower Costs, More Transparency Act; HR3561, PATIENT Act of 2023; S3394, Rural Emergency Hospital Adjustment Act;
HR977/S470, Patient Access to Higher Quality Health Care Act of 2023; HR5378, Lower Costs, More Transparency Act; HR3561, PATIENT Act of 2023; S3394, Rural Emergency Hospital Adjustment Act;"

You can find more data on corporate lobbying on Quiver Quantitative.

HCA Insider Trading Activity

HCA insiders have traded $HCA stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $HCA stock by insiders over the last 6 months:

• MICHAEL S. CUFFE (EVP and Chief Clinical Officer) sold 8,358 shares for an estimated $3,221,340
• KATHLEEN M WHALEN (SVP & Chief Ethics Officer) has made 0 purchases and 3 sales selling 6,325 shares for an estimated $2,284,372.
• CHRISTOPHER F. WYATT (SVP & Controller) sold 4,000 shares for an estimated $1,440,782
• PHILLIP G BILLINGTON (SVP-Internal Audit Services) sold 3,897 shares for an estimated $1,363,950
• DEBORAH M REINER (SVP - Mktg. & Communications) sold 3,314 shares for an estimated $1,192,914
• EROL R AKDAMAR (Group President) sold 2,900 shares for an estimated $1,023,700
• KATHRYN A. TORRES (SVP-Payer Contracting & Align.) sold 1,857 shares for an estimated $659,327

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

HCA Hedge Fund Activity

We have seen 524 institutional investors add shares of HCA stock to their portfolio, and 555 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• WELLINGTON MANAGEMENT GROUP LLP removed 3,726,592 shares (-34.6%) from their portfolio in Q3 2024, for an estimated $1,514,598,786
• FMR LLC added 2,397,883 shares (+322.3%) to their portfolio in Q3 2024, for an estimated $974,571,587
• PRICE T ROWE ASSOCIATES INC /MD/ removed 988,580 shares (-41.3%) from their portfolio in Q3 2024, for an estimated $401,788,569
• VANGUARD GROUP INC removed 821,571 shares (-4.9%) from their portfolio in Q3 2024, for an estimated $333,911,101
• BLACKROCK, INC. added 616,805 shares (+4.2%) to their portfolio in Q3 2024, for an estimated $250,688,056
• BANK OF AMERICA CORP /DE/ removed 572,101 shares (-14.3%) from their portfolio in Q3 2024, for an estimated $232,519,009
• ALLIANCEBERNSTEIN L.P. removed 424,263 shares (-30.4%) from their portfolio in Q3 2024, for an estimated $172,433,211

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.